93 related articles for article (PubMed ID: 30813877)
21. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
[TBL] [Abstract][Full Text] [Related]
22. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
Lee K; Lee AY; Kwon YK; Kwon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
[TBL] [Abstract][Full Text] [Related]
23. Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.
Schütze DM; Snijders PJ; Bosch L; Kramer D; Meijer CJ; Steenbergen RD
J Virol; 2014 Feb; 88(3):1714-24. PubMed ID: 24257607
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
Koivusalo R; Krausz E; Helenius H; Hietanen S
Mol Pharmacol; 2005 Aug; 68(2):372-82. PubMed ID: 15908516
[TBL] [Abstract][Full Text] [Related]
25. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
[TBL] [Abstract][Full Text] [Related]
26. Specific apoptosis induction in human papillomavirus-positive cervical carcinoma cells by photodynamic antisense regulation.
Yamayoshi A; Kato K; Suga S; Ichinoe A; Arima T; Matsuda T; Kato H; Murakami A; Wake N
Oligonucleotides; 2007; 17(1):66-79. PubMed ID: 17461764
[TBL] [Abstract][Full Text] [Related]
27. HPV-16 E7 protein bypasses keratinocyte growth inhibition by serum and calcium.
Pei XF; Sherman L; Sun YH; Schlegel R
Carcinogenesis; 1998 Aug; 19(8):1481-6. PubMed ID: 9744546
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus 16/18 E6 oncoprotein is expressed in lung cancer and related with p53 inactivation.
Cheng YW; Wu MF; Wang J; Yeh KT; Goan YG; Chiou HL; Chen CY; Lee H
Cancer Res; 2007 Nov; 67(22):10686-93. PubMed ID: 18006810
[TBL] [Abstract][Full Text] [Related]
29. Study of infectious virus production from HPV18/16 capsid chimeras.
Chen HS; Bromberg-White J; Conway MJ; Alam S; Meyers C
Virology; 2010 Sep; 405(2):289-99. PubMed ID: 20598725
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of hyperplasia induction by human papillomavirus E7.
Ueno T; Sasaki K; Yoshida S; Kajitani N; Satsuka A; Nakamura H; Sakai H
Oncogene; 2006 Jul; 25(30):4155-64. PubMed ID: 16501608
[TBL] [Abstract][Full Text] [Related]
31. Mitotic control of human papillomavirus genome-containing cells is regulated by the function of the PDZ-binding motif of the E6 oncoprotein.
Marsh EK; Delury CP; Davies NJ; Weston CJ; Miah MAL; Banks L; Parish JL; Higgs MR; Roberts S
Oncotarget; 2017 Mar; 8(12):19491-19506. PubMed ID: 28061478
[TBL] [Abstract][Full Text] [Related]
32. Notch1 signaling inhibits growth of EC109 esophageal carcinoma cells through downmodulation of HPV18 E6/E7 gene expression.
Zhang KJ; Lu QY; Niu XQ; Zhang P; Zhao JN; Wang Z; Hu JS; Li P; Liu WL
Acta Pharmacol Sin; 2009 Feb; 30(2):153-8. PubMed ID: 19122673
[TBL] [Abstract][Full Text] [Related]
33. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
[TBL] [Abstract][Full Text] [Related]
34. Gene expression profiles reveal an upregulation of E2F and downregulation of interferon targets by HPV18 but no changes between keratinocytes with integrated or episomal viral genomes.
Karstensen B; Poppelreuther S; Bonin M; Walter M; Iftner T; Stubenrauch F
Virology; 2006 Sep; 353(1):200-9. PubMed ID: 16814354
[TBL] [Abstract][Full Text] [Related]
35. HPV18 DNA replication inactivates the early promoter P
Wang X; Liu H; Wang HK; Meyers C; Chow L; Zheng ZM
Virol Sin; 2016 Oct; 31(5):437-440. PubMed ID: 27822719
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage.
Kessis TD; Slebos RJ; Nelson WG; Kastan MB; Plunkett BS; Han SM; Lorincz AT; Hedrick L; Cho KR
Proc Natl Acad Sci U S A; 1993 May; 90(9):3988-92. PubMed ID: 8387205
[TBL] [Abstract][Full Text] [Related]
37. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
[TBL] [Abstract][Full Text] [Related]
38. The E2F5 repressor is an activator of E6/E7 transcription and of the S-phase entry in HPV18-associated cells.
Teissier S; Pang CL; Thierry F
Oncogene; 2010 Sep; 29(36):5061-70. PubMed ID: 20639900
[TBL] [Abstract][Full Text] [Related]
39. Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China.
Xu HH; Zheng LZ; Lin AF; Dong SS; Chai ZY; Yan WH
Gene; 2018 Mar; 647():192-197. PubMed ID: 29331480
[TBL] [Abstract][Full Text] [Related]
40. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities.
Kehmeier E; Rühl H; Voland B; Stöppler MC; Androphy E; Stöppler H
Virology; 2002 Jul; 299(1):72-87. PubMed ID: 12167343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]